By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Neovacs SA 

3/5 Impasse Reille

Paris    75014  France
Phone: 33-0-153109300 Fax: 33-0-153109303



Company News
Neovacs : Successfully Raises €6.0 Million In Private Placement With U.S. Biotechnology Institutional Investors 7/31/2017 11:58:09 AM
Neovacs Announces FDA Acceptance Of A New IND To Expand In U.S. Ifnalpha Kinoid Clinical Development Program In Dermatomyositis 7/19/2017 11:22:16 AM
Neovacs Announces License Agreement For IFNalpha Kinoid For Treatment Of Lupus In Turkey 7/5/2017 11:07:20 AM
Neovacs Announces The Completion Of Patient Enrollment In Phase IIb Clinical Study Of IFNalpha Kinoid In Lupus 6/20/2017 10:20:10 AM
Neovacs And Lupus Europe Join Voices On World Lupus Day 5/10/2017 8:47:39 AM
Neovacs To Present Clinical Development Update On IFNa Kinoid in Dermatomyositis 5/4/2017 10:48:07 AM
Week In Review: BioSense Signs $68 Million China Deal With Neovacs For Therapeutic Vaccine 2/27/2017 8:40:16 AM
Neovacs 2017 Financial Calendar 2/7/2017 8:29:29 AM
Neovacs Obtains FDA “Fast Track” Designation For IFNa Kinoid In Lupus (SLE) 12/7/2016 8:06:59 AM
Neovacs Signs Production Partnership With 3P Biopharmaceuticals, A Leading GMP Producer Of Biological Drugs 11/28/2016 8:06:27 AM